![Richard P. Rieger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard P. Rieger
Nessuna posizione attualmente
Profilo
Richard P.
Rieger worked as Vice President of Business Development at Dendreon Corp.
and PhaseRx, Inc. He also worked as Vice President of Commercial Operations at Catalyst Pharmaceuticals, Inc. Rieger received an undergraduate degree from the University of Notre Dame and an MBA from the University of Chicago.
Precedenti posizioni note di Richard P. Rieger
Società | Posizione | Fine |
---|---|---|
PHASERX, INC. | Corporate Officer/Principal | - |
CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
DENDREON CORPORATION | Corporate Officer/Principal | - |
Formazione di Richard P. Rieger
The University of Chicago | Masters Business Admin |
University of Notre Dame | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
PHASERX, INC. | Health Technology |
CATALYST PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Dendreon Corp.
![]() Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Richard P. Rieger